
Détail de l'auteur
Auteur J. BRUNEAU |
Documents disponibles écrits par cet auteur (38)

![]()
Périodique
J. BRUNEAU ; M. DANIEL ; KESTENS Y. ; G. ZANG ; M. GENEREUX | 2008ENGLISH : BACKGROUND: Studies indicate that needle-exchange programmes (NEPs) can reduce the incidence of HIV infection; however, a positive impact of syringe-supply programmes has not been consistently demonstrated. The associations between h[...]![]()
Article : Périodique
D. JUTRAS-ASWAD ; G. ZANG ; J. BRUNEAU |This study examines whether the relation between acute cannabis use and syringe sharing during single injection days is similar among regular and nonregular users, participating in a cohort study of injection drug users in Montreal, Canada. 236 [...]![]()
Article : Périodique
P. LAUZON ; J. BRUNEAU ; REMONDIN M. ; S. BRISSETTE ; L. POTVIN ; J. M. BRODEUR |FRANÇAIS : Plusieurs études ont comparé l'efficacité de la clonidine et de la méthadone dans le traitement du syndrome de retrait des opiacés, sans mettre en évidence des différences importantes entre les deux médicaments sauf pour la présence [...]![]()
Article : Périodique
R. MOIRAND ; M. BILODEAU ; S. BRISSETTE ; J. BRUNEAU |FRANÇAIS : HISTORIQUE ET OBJECTIFS : Afin d'en accroître l'efficacité thérapeutique, la prestation du traitement antiviral contre le virus de l'hépatite C (VHC) devrait augmenter. Pourtant, l'expérience pratique révèle un faible taux de traitem[...]![]()
Périodique
B. FISHER ; S. BRISSETTE ; S. BROCHU ; J. BRUNEAU ; N. EL-GUEBALY ; L. NOEL ; J. REHM ; M. TYNDALL ; C. WILD ; MUN P. ; E. HAYDON ; D. BALIUNAS | 2004ENGLISH : Background: Drug overdose is a major cause of death and illness among illicit drug users. Previous research has indicated that most illicit drug users experience nonfatal overdoses and has suggested a variety of factors that are asso[...]![]()
Article : Périodique
J. GREBELY ; B. HAJARIZADEH ; J. V. LAZARUS ; J. BRUNEAU ; C. TRELOAR ; International Network on Hepatitis in Substance Users |There have been major strides towards the World Health Organization goal to eliminate hepatitis C virus (HCV) infection as a global public health threat. The availability of simple, well-tolerated direct-acting antiviral therapies for HCV infect[...]![]()
Bulletin : Périodique
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017![]()
Article : Périodique
P. LECLERC ; A. C. VANDAL ; A. FALL ; J. BRUNEAU ; E. ROY ; S. BRISSETTE ; C. P. ARCHIBALD ; N. ARRUDA ; C. MORISSETTE |Background: To plan and implement services to persons who inject drugs (PWID), knowing their number is essential. For the island of Montréal, Canada, the only estimate, of 11,700 PWID, was obtained in 1996 through a capture-recapture method. Thi[...]![]()
Périodique
N. CARRIER ; J. LAPLANTE ; J. BRUNEAU | 2005ENGLISH : Hepatitis C is an emerging theme of contemporary public health discourses related to illicit drug injection practices. Such discourses differentiate injecting from non-injecting users in an actuarial risk logic, targeting drug-inject[...]![]()
Article : Périodique
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY |We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]![]()
Périodique
J. BRUNEAU ; F. LAMOTHE ; FRANCO E. ; LACHANCE N. ; DESY M. ; SOTO J. ; VINCELETTE J. | 1997![]()
Périodique
MAKEDONAS G. ; J. BRUNEAU ; H. LIN ; SEKALY R. P. ; F. LAMOTHE ; N. F. BERNARD | 2002ENGLISH : Objectives: To determine whether HIV-exposed, uninfected subjects (EUs) having HIV-specific effector activity are at a reduced risk for seroconverting compared with EUs with no HIV-specific effector responses. Design: Twenty-eight in[...]![]()
Article : Périodique
E. FORTIER ; S. B. HOJ ; M. P. SYLVESTRE ; A. A. ARTENIE ; N. MINOYAN ; D. JUTRAS-ASWAD ; J. GREBELY ; J. BRUNEAU |Background: Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may affect HCV infection risk. Thus, this study[...]![]()
Article : Périodique
E. ROY ; N. ARRUDA ; P. LECLERC ; N. HALEY ; J. BRUNEAU ; J. F. BOIVIN |Background: Preparing drugs or medications for injection may leave residues in containers and filters used by injection drug users (IDUs). Little is known about the specific practice of injecting someone else's drug residue as a possible route o[...]